9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support

Core Knowledge: Agitation in the critically ill burn patient is a high-risk clinical emergency that threatens patient safety, compromises newly grafted surgical sites, accelerates metabolic demand, and predisposes to accidental self-extubation or vascular catheter dislodgement. Modern burn critical care mandates an analgesia-first (analgosedation) paradigm paired with targeted light sedation, prioritizing reversible physiological etiologies before administering sedative-hypnotic pharmacotherapy.

---

1. Etiological Hierarchy of Acute Agitation in Burn Patients

Agitation must never be reflexively suppressed with sedatives without a thorough, systematic diagnostic evaluation. In the burn ICU, acute motor restlessness, combative behavior, or ventilator dyssynchrony frequently signals life-threatening hypoxemia, acute hypercapnia, or unaddressed somatic pain.

                         DIAGNOSTIC HIERARCHY OF ACUTE AGITATION
  ┌────────────────────────────────────────────────────────────────────────┐
  │ Step 1: Rule Out Immediate Hypoxemia, Hypercapnia & Airway Compromise  │
  │         (ABG, continuous SpO2, EtCO2, endotracheal tube positioning)   │
  ├────────────────────────────────────────────────────────────────────────┤
  │ Step 2: Assess and Treat Uncontrolled Nociceptive / Neuropathic Pain   │
  │         (CPOT / BPS / NRS; deploy IV opioid / ketamine bolus)          │
  ├────────────────────────────────────────────────────────────────────────┤
  │ Step 3: Identify Toxic Inhalant Encephalopathy & Metabolic Crises      │
  │         (COHb, Cyanide toxicity, Hypoglycemia, Electrolyte collapse)   │
  ├────────────────────────────────────────────────────────────────────────┤
  │ Step 4: Screen for Substance Withdrawal Syndromes                      │
  │         (Alcohol [CIWA-Ar], Nicotine, Opioid, Benzodiazepine)          │
  ├────────────────────────────────────────────────────────────────────────┤
  │ Step 5: Alleviate Physical Distress, Urinary Retention & Constriction  │
  │         (Bladder distension, occlusive dressing pressure, ischemia)    │
  ├────────────────────────────────────────────────────────────────────────┤
  │ Step 6: Modulate Environmental Overstimulation & Sleep Fragmentation   │
  │         (ICU noise >80 dB, constant illumination, sensory overload)    │
  └────────────────────────────────────────────────────────────────────────┘

Primary Etiologies of Burn Agitation:

1. Uncontrolled Pain: Severe background, procedural, or breakthrough pain is the single most common cause of acute agitation. Burn wounds, donor sites, and tight dressings generate massive nociceptive C-fiber and A-delta signaling.
2. Respiratory Failure & Hypoxia/Hypercapnia: Upper airway edema, bronchospasm, mucus plugging, acute respiratory distress syndrome (ARDS), or ventilator dyssynchrony trigger profound air hunger and hyperadrenergic agitation.
3. Toxic Inhalant Toxicity & Encephalopathy: Inhalation injury patients may suffer acute cerebral hypoxia from carbon monoxide (COHb poisoning causing cellular asphyxiation) or hydrogen cyanide (inhibition of cytochrome c oxidase), producing acute encephalopathy and combativeness.
4. Substance Withdrawal Syndromes:
   • Alcohol Withdrawal Syndrome (AWS): Tremors, autonomic hyperactivity (hypertension, tachycardia, diaphoresis), hallucinations, and delirium tremens (DTs) typically manifest within 24 to 72 hours post-admission.
   • Nicotine / Opioid / Polysubstance Withdrawal: Precipitates hyperarousal, nausea, abdominal cramping, and severe restlessness.
5. Sepsis-Associated Encephalopathy (SAE): Systemic endotoxemia, cytokine release (TNF-α, IL-1β, IL-6), and blood-brain barrier disruption manifest as acute delirium and fluctuating agitation.
6. Physical Discomfort & Iatrogenic Restraints: Full urinary bladder distension, malpositioned nasogastric tubes, restrictive splints/dressings, and physical wrist restraints amplify anxiety and trigger violent struggling.

---

2. Objective Sedation Scoring Systems: RASS vs. SAS

Objective sedation scales are essential to standardize titration, prevent iatrogenic over-sedation, and establish a common clinical language across the multidisciplinary burn team. The Society of Critical Care Medicine (SCCM) Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption (PADIS) recommend using either the Richmond Agitation-Sedation Scale (RASS) or the Riker Sedation-Agitation Scale (SAS).

                       OBJECTIVE SEDATION ASSESSMENT SCALES
  ┌────────────────────────────────────────┬────────────────────────────────────────┐
  │   RICHMOND AGITATION-SEDATION (RASS)   │    RIKER SEDATION-AGITATION (SAS)      │
  ├────────────────────────────────────────┼────────────────────────────────────────┤
  │  +4  Combative, violent, danger to self│   7   Dangerous Agitation (pulls tube) │
  │  +3  Very agitated, aggressive         │   6   Very Agitated (requires restraint)│
  │  +2  Agitated, frequent unprompted mvmt│   5   Agitated (calms with verbal cue) │
  │  +1  Restless, anxious, apprehensive   │   4   Calm and Cooperative [TARGET]    │
  │   0  Alert and Calm [TARGET]           │   3   Sedated (difficulty waking) [TGT]│
  │  -1  Drowsy (eye open >10s to voice)   │   2   Very Sedated (arouses to stimuli)│
  │  -2  Light sedation (eye open <10s)    │   1   Unarousable (minimal/no response)│
  │  -3  Moderate sedation (no eye contact)│                                        │
  │  -4  Deep sedation (movement to phys)  │                                        │
  │  -5  Unarousable (no response)         │                                        │
  └────────────────────────────────────────┴────────────────────────────────────────┘

The Light Sedation Mandate in Burn Care

Except in specific clinical circumstances requiring deep sedation (e.g., severe ARDS with neuromuscular blockade, open surgical abdomens, intracranial hypertension, or refractory status epilepticus), the universal clinical target is Light Sedation:

• RASS Target: -1 to 0 (Drowsy to Alert and Calm).
• SAS Target: 3 to 4 (Sedated to Calm and Cooperative).

Clinical Benefits of Targeted Light Sedation:

• Preserves patient ability to interact with the environment and participate in physical therapy.
• Allows reliable, serial neurological and delirium assessments (CAM-ICU).
• Facilitates spontaneous breathing trials (SBTs) and accelerates successful extubation.
• Reduces the duration of mechanical ventilation and ICU length of stay by up to 30–40%.
• Decreases the incidence of deep venous thrombosis (DVT) and pressure injuries through spontaneous extremity motion.

---

3. Sedative Pharmacotherapy in Burn Intensive Care

The SCCM PADIS guidelines strongly endorse an analgesia-first (analgosedation) framework. Opioids and non-opioid analgesics (e.g., IV ketamine, acetaminophen, gabapentinoids) should be optimized to control pain before initiating or up-titrating sedative infusions.

---

4. Propofol Infusion Syndrome (PRIS): Pathophysiology and Surveillance

Propofol Infusion Syndrome (PRIS) is a catastrophic, frequently fatal metabolic crisis triggered by prolonged, high-dose propofol administration. It is especially lethal in burn patients due to their pre-existing hypermetabolism and systemic inflammatory state.

                         PATHOPHYSIOLOGY OF PROPOFOL INFUSION SYNDROME
  ┌────────────────────────────────────────────────────────────────────────┐
  │ Prolonged High-Dose Propofol (>4–5 mg/kg/hr or >67–83 mcg/kg/min >48h) │
  │                                    │                                   │
  │                                    ▼                                   │
  │ Direct Inhibition of Mitochondrial Electron Transport Chain (Complex IV)│
  │ & Blockade of Medium/Long-Chain Fatty Acid Entry into Mitochondria     │
  │                                    │                                   │
  │                                    ▼                                   │
  │   Severe Cellular Bioenergetic Starvation & Anaerobic Glycolysis Shift │
  │                                    │                                   │
  │                                    ▼                                   │
  │  Massive Skeletal / Myocardial Muscle Lysis & Hepatosplenomegaly       │
  │                                    │                                   │
  │                                    ▼                                   │
  │ • Refractory Anion Gap Metabolic Acidosis with Lactic Acidemia         │
  │ • Severe Hyperkalemia & Massive Rhabdomyolysis (Spike in Serum CK)     │
  │ • Acute Renal Pigmentary Failure (Myoglobinuria / Oliguria)            │
  │ • Malignant Cardiac Collapse (Brugada Waveform, Bradycardia, Asystole) │
  └────────────────────────────────────────────────────────────────────────┘

Clinical Triggers & Safe Practice Benchmarks:

• High-Risk Thresholds: Propofol infusion rates $>4\text{ to }5\text{ mg/kg/hr}$ (or $>67\text{ to }83\text{ mcg/kg/min}$) maintained for $>48\text{ hours}$.
• Concomitant Risk Factors: Exogenous catecholamine infusions (epinephrine/norepinephrine), systemic corticosteroid therapy, young age, and severe critical illness.
• Mandatory Nursing Surveillance:
  1. Obtain baseline and daily serum triglycerides, creatine kinase (CK), and arterial blood gases (lactate/base deficit).
  2. Continuous 12-lead telemetry monitoring for widening QRS complexes, right bundle branch block with ST elevation in leads V1–V3 (coved Brugada-like ECG pattern), and refractory bradycardia.
  3. If PRIS is suspected: Immediately terminate the propofol infusion, transition to alternative sedatives (dexmedetomidine, ketamine, or hydromorphone), support hemodynamics (pacing, ECMO if refractory), and initiate continuous renal replacement therapy (CRRT) to clear toxins and correct hyperkalemic acidosis.

---

5. Sleep Architecture Disruption in the Burn ICU

Sleep deprivation is nearly universal in critically ill burn patients, with polysomnography demonstrating almost complete ablation of slow-wave restorative sleep (Stage N3) and Rapid Eye Movement (REM) sleep. This architectural disruption impairs wound healing, worsens hypermetabolism, escalates pain perception (hyperalgesia), and directly triggers ICU delirium.

                   ETIOLOGIES OF BURN ICU SLEEP FRAGMENTATION
  ┌────────────────────────────────────────────────────────────────────────┐
  │  Acoustic Disturbances: Monitor alarms, mechanical ventilators, staff  │
  │  conversations, pneumatic tube deliveries (>65–80 dB; normal <45 dB)   │
  ├────────────────────────────────────────────────────────────────────────┤
  │  Optical Disruption: Continuous fluorescent room lighting abverts      │
  │  retinal suprachiasmatic nucleus signaling, abolishing melatonin peak  │
  ├────────────────────────────────────────────────────────────────────────┤
  │  Nursing Care Interventions: Vital signs q1h, blood draws, dressing    │
  │  inspections, turns, and medication administration every 30–60 minutes │
  ├────────────────────────────────────────────────────────────────────────┤
  │  Physiological & Pharmacological Stressors: Severe background burn     │
  │  pain, pruritus, systemic hypermetabolic catecholamine storm, opioids  │
  └────────────────────────────────────────────────────────────────────────┘

Multicomponent Sleep Hygiene Bundle (Circadian Protocol):

To restore circadian entrainment and promote endogenous melatonin secretion, burn units implement standardized non-pharmacological sleep bundles:

1. Circadian Lighting Regulation:
   • Daytime (07:00–21:00): Open window shades, maximize exposure to natural sunlight, maintain bright ambient room lighting ($>300\text{ lux}$) to reinforce wakefulness.
   • Nighttime (22:00–06:00): Dim room lights ($<30\text{ lux}$), turn off overhead spotlights, minimize computer terminal glare.
2. Clustering Nighttime Nursing Care:
   • Consolidate routine blood sampling, linen changes, dressing changes, and non-emergent medication administration during daytime hours.
   • Establish a protected "Quiet Time" window (23:00 to 05:30) where patient entries are limited to strictly essential critical checks.
3. Acoustic & Sensory Attenuation:
   • Maintain ICU sound levels $<45\text{ dB}$ at night by lowering telemetry and infusion pump alarm volumes to safe minimum thresholds.
   • Provide high-attenuation foam earplugs and contoured eye sleep masks to every conscious patient.
   • Deploy continuous low-frequency white noise or calming ambient music.
4. Pharmacological Circadian Promotion:
   • Exogenous Melatonin: Administer 3 to 10 mg PO/NG at 21:00 to induce physiological sleep phase advancement and provide antioxidant cytoprotection.
   • Melatonin Receptor Agonists: Ramelteon (8 mg PO) selectively binds MT1 and MT2 receptors without hypnotic hangover or respiratory depression.
   • Avoid Deliriogenic Nighttime Sedation: Strictly avoid routine nighttime benzodiazepines (lorazepam/temazepam) or antihistamines (diphenhydramine), as they extinguish REM architecture and worsen confusion.